Yup heart surgery is probably completely and utterly out of reach of the majority of the population. Market size? Maybe a rough guide would be to apply the incidence/prevalence of CHD in the population that has private health insurance (going by the above link, thats about 5% of the population or 66 million have private health insurance).
Using the figures used by other posters:
Number of private health insured = 66 million
Population growth = 2% x 66 million = 1.3 million p.a.
Incidence of CHD = 1% x 1.3 million = 13,200 p.a.
Number of operations = 25% x 13,200 = 3,300 p.a.
The country in itself wont be a company maker but its another market to add to the list and for sure over time a progressively larger segment of the population in India will join the ranks of those that can afford proper healthcare.
- Forums
- ASX - By Stock
- AVR
- Ann: Regulatory approval to launch CardioCel in India
Ann: Regulatory approval to launch CardioCel in India, page-64
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$18.31 |
Change
-0.240(1.29%) |
Mkt cap ! $351.9M |
Open | High | Low | Value | Volume |
$18.80 | $19.15 | $18.20 | $159.7K | 8.611K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 73 | $18.31 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$18.33 | 90 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 73 | 18.310 |
1 | 150 | 18.100 |
1 | 20 | 18.060 |
1 | 100 | 18.050 |
1 | 250 | 18.010 |
Price($) | Vol. | No. |
---|---|---|
18.330 | 90 | 1 |
19.000 | 9589 | 2 |
19.030 | 467 | 1 |
19.290 | 325 | 1 |
19.800 | 264 | 1 |
Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online